Literature DB >> 18023224

Monogenic pediatric dyslipidemias: classification, genetics and clinical spectrum.

Amit R Rahalkar1, Robert A Hegele.   

Abstract

Monogenic disorders that cause abnormal levels of plasma cholesterol and triglycerides have received much attention due to their role in metabolic dysfunction and cardiovascular disease. While these disorders often present clinically during adulthood, some present most commonly in the pediatric population and can have serious consequences if misdiagnosed or untreated. This review provides an overview of monogenic lipid disorders that present with unusually high or low levels of plasma cholesterol and/or triglycerides during infancy, childhood and adolescence. Biochemical and genetic findings, clinical presentation and treatment options are discussed with an emphasis upon recent advances in our understanding and management of these monogenic disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023224     DOI: 10.1016/j.ymgme.2007.10.007

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  25 in total

1.  Childhood risk factors predict cardiovascular disease, impaired fasting glucose plus type 2 diabetes mellitus, and high blood pressure 26 years later at a mean age of 38 years: the Princeton-lipid research clinics follow-up study.

Authors:  John A Morrison; Charles J Glueck; Ping Wang
Journal:  Metabolism       Date:  2011-10-14       Impact factor: 8.694

2.  Hypertrophic cardiomyopathy with familial chylomicronemia syndrome: is it an incidental finding or a new association?

Authors:  Mehmet Gündüz; Nevra Koç; Eda Özaydın; Filiz Ekici
Journal:  Indian J Pediatr       Date:  2014-02-05       Impact factor: 1.967

Review 3.  Chylomicronaemia--current diagnosis and future therapies.

Authors:  Amanda J Brahm; Robert A Hegele
Journal:  Nat Rev Endocrinol       Date:  2015-03-03       Impact factor: 43.330

4.  Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.

Authors:  R P Surendran; M E Visser; S Heemelaar; J Wang; J Peter; J C Defesche; J A Kuivenhoven; M Hosseini; M Péterfy; J J P Kastelein; C T Johansen; R A Hegele; E S G Stroes; G M Dallinga-Thie
Journal:  J Intern Med       Date:  2012-02-13       Impact factor: 8.989

Review 5.  Genetics of familial hypercholesterolemia.

Authors:  Ariel Brautbar; Emili Leary; Kristen Rasmussen; Don P Wilson; Robert D Steiner; Salim Virani
Journal:  Curr Atheroscler Rep       Date:  2015-04       Impact factor: 5.113

Review 6.  Approach to the interpretation of unexpected laboratory results arising in the care of patients with inborn errors of metabolism (IEM).

Authors:  Andre Mattman; Murray Potter
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

Review 7.  Toxic-metabolic Risk Factors in Pediatric Pancreatitis: Recommendations for Diagnosis, Management, and Future Research.

Authors:  Sohail Z Husain; Veronique Morinville; John Pohl; Maisam Abu-El-Haija; Melena D Bellin; Steve Freedman; Peter Hegyi; Melvin B Heyman; Ryan Himes; Chee Y Ooi; Sarah J Schwarzenberg; Danielle Usatin; Aliye Uc
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-04       Impact factor: 2.839

8.  An infant with milky blood : an unusual but treatable case of familial hyperlipidemia.

Authors:  Om Shankar Chaurasiya; Lalit Kumar; Rohit Shamsher Sethi
Journal:  Indian J Clin Biochem       Date:  2012-12-11

Review 9.  Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.

Authors:  Anna Wolska; Richard L Dunbar; Lita A Freeman; Masako Ueda; Marcelo J Amar; Denis O Sviridov; Alan T Remaley
Journal:  Atherosclerosis       Date:  2017-10-20       Impact factor: 5.162

10.  Association of the FRMD5 rs2929282 polymorphism and serum lipid profiles in two Chinese ethnic groups.

Authors:  Hui Gao; Rui-Xing Yin; Qing-Hui Zhang; Ling Qiu; Eksavang Khounphinith; Duo-Shun Wang; Kai-Guang Li
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.